Cargando…

IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications

Interleukin 17A (IL-17A) is one of the currently known six members of the IL-17 cytokine family and is implicated in immune responses to infectious pathogens and in the pathogenesis of inflammatory autoimmune diseases like psoriasis. Psoriatic skin is characterized by high expression of IL-17A and I...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Stebut, Esther, Boehncke, Wolf-Henning, Ghoreschi, Kamran, Gori, Tommaso, Kaya, Ziya, Thaci, Diamant, Schäffler, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974482/ https://www.ncbi.nlm.nih.gov/pubmed/32010143 http://dx.doi.org/10.3389/fimmu.2019.03096

Ejemplares similares

The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2018)

The Clinical Significance of Simultaneous IL-17A and IL-17F Blockade in Psoriasis Non-Responding to Anti-IL17A Therapy
por: Kokolakis, Georgios, et al.
Publicado: (2022)

Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences
por: Boehncke, Wolf-Henning
Publicado: (2018)

Revisiting the interleukin 17 family of cytokines in psoriasis: pathogenesis and potential targets for innovative therapies
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2023)

Efalizumab in the treatment of psoriasis
por: Boehncke, Wolf-Henning
Publicado: (2007)

Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care
por: da Silva, Neuza, et al.
Publicado: (2020)

The role of IL‐23 and the IL‐23/T(H)17 immune axis in the pathogenesis and treatment of psoriasis
por: Girolomoni, G., et al.
Publicado: (2017)

Treatment Options and Goals for Patients with Generalized Pustular Psoriasis
por: Krueger, James, et al.
Publicado: (2022)

Spotlight on Topical Long-Term Management of Plaque Psoriasis
por: Carrascosa, Jose Manuel, et al.
Publicado: (2020)

Advances in treating psoriasis
por: Belge, Katharina, et al.
Publicado: (2014)

Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
por: Forchhammer, Stephan, et al.
Publicado: (2015)

Phytotherapeuthics Affecting the IL-1/IL-17/G-CSF Axis: A Complementary Treatment Option for Hidradenitis Suppurativa?
por: Witte, Katrin, et al.
Publicado: (2022)

Association between IL-17F, IL-17RA Gene Polymorphisms and Response to Biological Drugs in Psoriasis and Beyond
por: Pușcaș, Alexandra Dana, et al.
Publicado: (2023)

Paradoxical improvement of life quality in the COVID-19 era in psoriasis patients
por: Boch, Katharina, et al.
Publicado: (2022)

Successful Treatment of Refractory Palmoplantar Pustular Psoriasis With Apremilast: A Case Series
por: Ständer, Sascha, et al.
Publicado: (2020)

Recent advances in understanding psoriasis
por: Eberle, Franziska C., et al.
Publicado: (2016)

The Role of IL-17 Cytokines in Psoriasis
por: Mosca, Megan, et al.
Publicado: (2021)

Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population Survey
por: Tillett, William, et al.
Publicado: (2020)

The contribution of IL-17 to the development of autoimmunity in psoriasis
por: Furue, Masutaka, et al.
Publicado: (2019)

In vivo reflectance confocal microscopy: a useful non-invasive tool to assess the response to isolated limb perfusion for superficial pigmented melanoma in-transit metastatic disease. Report of a case
por: Merat, Rastine, et al.
Publicado: (2017)

Involvement of IL-9 in Th17-Associated Inflammation and Angiogenesis of Psoriasis
por: Singh, Tej Pratap, et al.
Publicado: (2013)

Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)
por: Wasel, Norman, et al.
Publicado: (2020)

Psoriasis and Cardiovascular Disease: Lesion Beyond the Skin
por: Bacchiega, Bruno Cesar
Publicado: (2019)

IL‐38 orchestrates proliferation and differentiation in human keratinocytes
por: Mermoud, Loïc, et al.
Publicado: (2022)

Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis: report on five cases
por: Mössner, Rotraut, et al.
Publicado: (2008)

Case report: Clinical features of COVID-19 vaccine-induced exacerbation of psoriasis–A case series and mini review
por: Ständer, Sascha, et al.
Publicado: (2022)

Case report: Optical coherence tomography for monitoring biologic therapy in psoriasis and atopic dermatitis
por: Ha-Wissel, Linh, et al.
Publicado: (2022)

Efficacy of Tildrakizumab Across Different Body Weights in Moderate-to-Severe Psoriasis Over 5 Years: Pooled Analyses from the reSURFACE Pivotal Studies
por: Thaçi, Diamant, et al.
Publicado: (2022)

General practice recommendations for the topical treatment of psoriasis: a modified-Delphi approach
por: Thaçi, Diamant, et al.
Publicado: (2020)

Differentiation of IL-26(+) T(H)17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis
por: Fries, Anissa, et al.
Publicado: (2023)

The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
por: Blauvelt, Andrew, et al.
Publicado: (2018)

Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
por: Hanley, Tessa L, et al.
Publicado: (2017)

Secukinumab: The Anti-IL-17A Biologic for the Treatment of Psoriasis
por: Fargnoli, Maria Concetta
Publicado: (2019)

Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin
por: Furue, Masutaka, et al.
Publicado: (2017)

Beyond the Skin Plaques: Psoriasis and Its Cardiovascular Comorbidities
por: Kakarala, Chandra L, et al.
Publicado: (2021)

Safety of Brodalumab in Plaque Psoriasis: Integrated Pooled Data from Five Clinical Trials
por: REICH, Kristian, et al.
Publicado: (2022)

Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors
por: Huang, Yu-Huei, et al.
Publicado: (2023)

An Analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R Expression and Their Correlation with Clinical Course in Patients with Psoriasis
por: Kutwin, Magdalena, et al.
Publicado: (2021)

Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness
por: Nicolescu, Alin Codrut, et al.
Publicado: (2022)

Literature Overview of the IL-17 Inhibition from Psoriasis to COVID-19
por: Zou, Yulin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5fjl1e8pj82jipioob4hbgn66h